Blood and Human Physiology

Blood

Components of Blood

  • Blood consists of living and non-living components.

    • The living component consists of three types of cells.

    • The non-living component is the plasma.

Plasma Constituents

  • Plasma Constituent and Function:

    • Water: Serves as a solvent and medium for transporting materials.

    • Albumin: Maintains osmotic pressure and transports substances.

    • Gamma Globulins: Are antibodies that play a role in immune response.

    • Fibrinogen: Involved in blood clotting.

    • Nutrients and Wastes: Transport of nutrients and metabolic waste.

    • Salts: Electrolyte balance.

    • Gases: Transport of oxygen and carbon dioxide.

Role of Blood Cells

  • Erythrocytes (Red Blood Cells):

    • Carry oxygen from the lungs to body tissues.

    • Contain hemoglobin, an oxygen-binding protein.

  • Leukocytes (White Blood Cells):

    • Five different types divided into two categories: Granulocytes and Agranulocytes.

    • Granulocytes:

    • Neutrophil:

      • A granulocytic WBC.

      • Functions to phagocytize bacteria.

      • Increased numbers indicate a bacterial infection.

    • Eosinophil:

      • A granulocytic WBC involved in allergy and parasitic worm destruction.

      • Has red cytoplasmic granules.

    • Basophil:

      • A granulocytic WBC involved in inflammation.

      • Contains blue cytoplasmic granules filled with histamine.

    • Agranulocytes:

    • Lymphocyte:

      • An agranulocytic WBC involved in immunity.

      • B Lymphocytes: Produce antibodies.

      • T Lymphocytes: Directly attack foreign cells.

    • Monocyte:

      • An agranulocytic WBC functioning in phagocytosis of bacteria in long-standing infections.

      • The largest leukocyte.

  • Platelets (Thrombocytes):

    • Cytoplasmic fragments of a larger cell, the megakaryocyte.

    • Functions in hemostasis (stopping bleeding).

Hematopoiesis

  • The process of blood cell formation.

  • Occurs in red bone marrow from stem cells called hemocytoblasts.

  • Differentiation to:

    • Common Myeloid Progenitor yields:

    • Erythrocytes

    • Platelets

    • Basophils

    • Neutrophils

    • Eosinophils

    • Common Lymphoid Progenitor yields:

    • T Lymphocytes

    • B Lymphocytes

Erythropoiesis

  • The formation of red blood cells occurs in red bone marrow.

    • From hemocytoblast to reticulocyte maturity.

    • Reticulocyte Count: A measurement indicating the level of erythropoiesis occurring.

  • Erythropoietin:

    • A hormone released from the kidney in response to low blood pO₂.

    • Stimulates erythropoiesis.

    • Key factors:

    • Hypoxemia: Inadequate oxygen transport in blood.

    • Stimulates increased RBC count and accelerated erythropoiesis.

  • Conditions of Low pO₂:

    • Low RBC numbers (anemia).

    • High altitude due to lower atmospheric pressure.

    • Athletes: Use high-altitude simulation tents to induce increased erythropoiesis and enhance oxygen capacity.

Life History of Red Blood Cells

  • RBCs lack a nucleus and do not carry out mitosis.

  • Produced in red bone marrow (erythropoiesis), with a lifespan of approximately 120 days.

  • Destruction occurs in small capillaries of the spleen and liver.

Breakdown of Hemoglobin
  • Iron from heme is recycled.

  • Globin's amino acids are also recycled.

Porphyrin Ring Breakdown
  • The porphyrin ring is converted to bilirubin, which is lipid-soluble.

  • Bilirubin is transported to the liver, modified with glucuronic acid, forming conjugated bilirubin (water-soluble) which is expelled with bile into the intestines and exits with stool.

Blood Types

  • Antigens (Agglutinogens): Present on RBC membranes and act as 'nametags.'

  • Antibodies (Agglutinins): Present in plasma; will destroy cells with non-self antigens.

    • Types: A, B, AB, O blood types.

  • Rh System:

    • Rh+: Possesses the Rh antigen.

    • Rh-: Lacks the Rh antigen; may produce antibodies against Rh.

    • Risks occur when an Rh- mother is pregnant with an Rh+ baby, leading to erythroblastosis fetalis (hemolytic disease of the newborn).

Hemostasis

  • Defined as the stoppage of bleeding, comprising three phases:

    1. Vasospasm: Reflexive narrowing of the blood vessels, mediated by serotonin; reduces blood loss.

    2. Platelet Plug Formation: Platelets adhere to exposed collagen fibers, stimulated by ADP and Thromboxane A2, leading to further platelet aggregation.

    3. Coagulation (Clotting): Involves intrinsic and extrinsic pathways that rely on calcium ($Ca^{2+}$) and clotting factors generated by the liver, with Vitamin K supporting the formation.

Pathways of Coagulation
  • Intrinsic Pathway:

    • Occurs in 3-6 minutes from damage to the blood vessel wall, mainly stimulated by the platelet plug.

    • Involves clotting factors including XII, XI, IX, VIII, and X.

  • Extrinsic Pathway:

    • Occurs in 15 seconds following damage to both the vessel wall and surrounding tissues.

    • Involves tissue thromboplastin, VII, and X.

Summary of Coagulation
  • Clots form through a meshwork of fibrin trapping blood cells and are initiated by thrombin.

  • Clot retraction occurs as the clot shrinks, bringing vessel edges closer, facilitating repair by PDGF secreted by platelets.

Dissolution of Clot
  • TPA (Tissue Plasminogen Activator): Released by healed endothelial cells, leading to the activation of plasmin, which dissolves the clot.

Risks of Clots
  • Potential dangers from clots include thrombi (stationary clots) and emboli (travelling clots), leading to conditions such as strokes, heart attacks, or pulmonary emboli, which may be life-threatening.

Conditions Affecting Clot Formation
  • Clots may form due to conditions such as:

    • Atherosclerosis (rough tissue triggering clot formation).

    • Blood stasis (pooling which activates clotting factors).

Inhibition of Clot Formation
  • Aspirin: Reduces thromboxane A2 to inhibit platelet plug formation.

  • Antithrombin III: Binds and inactivates thrombin, inhibiting clot formation.

  • Heparin: Increases antithrombin III activity, also preventing clot formation.